Volume 70, Issue 4 , Pages 152-158, April 2007
Alpha 2,6-Sialyltransferase I Expression in the Placenta of Patients with Preeclampsia
Article Outline
Background
The expression of sialyl-glycoconjugates changes during development, differentiation and oncogenic transformation, tumor invasion and metastasis. Similarly, in the early stage of pregnancy, trophoblast cells have to undergo adhesion, invasion, and proliferation to develop a healthy placenta; the cytobiologic behavior is similar to tumor growth and invasion. Inadequate trophoblast invasion to the spiral artery in the 2nd trimester of pregnancy was believed to be correlated with pregnancy complications, including preeclampsia.
Methods
Alterations in α2,6-sialyltransferase I (ST6Gal I) mRNA in the placental tissues of women with preeclampsia (n = 20) and without preeclampsia (n = 20 used as a control) were examined by semiquantitative reverse transcription-polymerase chain reaction and real-time quantitative reverse transcription-polymerase chain reaction. The transcription regulators of ST6Gal I including a “constitutive” promoter (Y + Z form), “hepatic” promoter (H form), and lymphoblastic promoter (X form) were investigated. The enzyme activity of ST6Gal I was also examined.
Results
Both mRNA expression and enzyme activity of ST6Gal I did not show a significant difference in the placental tissues of the women of both groups. The transcription regulators of ST6Gal I, including the Y + Z form and the H form, also failed to show any difference. The X form, seldom detected in the study, was excluded from analysis.
Conclusion
Our results suggested that ST6Gal I was not involved in the pathogenesis of the preeclampsia.
Key Words: α2 , 6-sialyltransferase I , placenta , preeclampsia , pregnancy
No full text is available. To read the body of this article, please view the PDF online.
References
- . Altered mRNA expression of glycosyltransferase in human colorectal carcinomas and liver metastases . Gut . 2000;46:359–366
- . Altered sialylation and sialyltransferase expression in gynecologic cancers . Taiwanese J Obstet Gynecol . 2004;43:53–63
- . Cell surface sialic acid as a mediator of metastatic potential in colorectal cancer . Cancer J . 1996;9:1–10
- . Sialic acids and their role as biological masks . Trends Biochem Sci . 1985;10:357–360
- Molecular cloning and expression of human Galβ1, 3GalNaca2,3-sialyltransferase (hST3GalII) . Biochem Biophys Res Commun . 1996;228:324–327
- . Possible roles of tumor-associated carbohydrate antigens . Cancer Res . 1996;56:2237–2244
- . Tumor malignancy defined by aberrant glycosylation and shingo-(glyco)-lipid metabolism . Cancer Res . 1996;56:5309–5318
- . Genetic detection of lymph node micrometastases in patients with colorectal cancer . Br J Surg . 1998;85:98–100
- . Restoration of a(l,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells . Cancer Res . 2000;60:1449–1456
- . SoyasaponinT modified invasive behavior of cancer by changing cell surface sialic acids . Gynecol Oncol . 2005;96:415–422
- . α2,6-sialylation of cell-surface N-glycans inhibits glioma formationin vivo . Cancer Res . 2001;61:6822–6829
- . Overexpression of sialyltransferase CMP-sialic acid: Gaipi,3GalNAc-Ra6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas . Cancer Res . 2001;61:4605–4611
- . Altered mRNA expression of sialyltransferase in squa-mous cell carcinomas of the cervix . Gynecol Oncol . 2001;83:121–127
- Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis . Gynecol Oncol . 2002;86:45–52
- . Sialyltransferase family members and cervix squamous cell carcinoma . Eur J Gynaecol Oncol . 2002;23:514–518
- . Altered glycosylation in cancer: sialic acids and sialyltransferase . J Cancer Mol . 2005;1:73–81
- . Color Doppler ultrasound of spiral arteries in normal second-trimester pregnancies . J Chin Med Assoc . 1997;59:289–294
- . Interest in preeclampsia for researchers in reproduction . J Reprod Immunol . 2002;52:279–287
- . Pathophysiology of hypertension during preeclampsia linking placental ischemia with endometrial dysfunction . Hypertension . 2001;38:718–722
- . Human liver and human placenta both contain CMP-NeuAc:Galβ1->4GlcNAc-R α2->3- as well as α2->6-sialyl-transferase activity . FEBSLett . 1992;312:31–36
- . Molecular cloning and functional analysis of sialyltrans-ferases . J Biochem . 1996;120:1–13
- Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma . Gynecol Oncol . 2003;89:395–401
- Altered mRNA expressions of sialyltransferases in ovarian cancers . Gynecol Oncol . 2005;99:631–639
- . Housekeeping genes as internal standards in cancer research . Mol Diajjn . 2004;8:107–113
- . High-resolution semiquantitative real-time PCR without the use of a standard curve . Biotechniques . 2001;31:502–507
- . Retinal VEGF mRNA measured by SYBR Green I fluorescence: a versatile approach to quantitative PCR . Mol Diagn . 2000;6:178–183
- Subfertility and defective folliculogenesis in female mice lacking androgen receptor . Proc Natl Acad Sci USA . 2004;101:11209–11214
- Different enzyme activities of sialyltransferases in gynecological cancer cell lines . Eur J Gynecol Oncol . 2002;23:221–226
- . Cloning and expression of Gal_l,3GalNAc-specific GalNAc_2,6-sialyltransferase . J Biol Chem . 1994;269:19048–19053
- . Recent developments in obstetrics . BMJ . 2003;327:604–608
- . Soyasaponin I decreases the expression of a2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells . Biochem Biophys Res Commun . 2006;341:614–619
- . Altered sialylation and its role in gynecological cancers . J Cancer Mol . 2006;2:107–116
- . Elevation of alpha2-> 6 sialyltransferase and alphal-> 2 fucosyl-transferase activities in human choriocarcinoma . Cancer Res . 1998;58:4301–4306
- . The sialyl-a2,6-lactosaminyl-structure: biosynthesis and functional role . Glycoconj J . 2000;17:669–676
- . Gene structure and transcriptional regulation of human Gaipi,4(3) GlcNAc a2,3-sialyltransferase VI (hST3Gal VI) gene in prostate cancer cell line . Biochem Biophys Res Commun . 2001;287:1148–1156
- . Transcriptional regulation of human beta-galactosidea2,6-sialyltransferase (hST6Gal I) gene during differentiation of the HL-60 cell line . Glycobiolojjy . 2000;10:623–628
- . Regulated expression of a2,6-sialyltransferase by the liver-enriched transcription factors HNF-1, DBP, and LAP . J Biol Chem . 1992;267:3466–3472
- . Rat Pgalactoside a2,6-sialyltransferase genomic organization: alternate promoters direct the synthesis of liver and kidney transcripts . Glycobiolojjy . 1990;1:25–31
- . Enhanced activity of CMP-NeuAcGal pi-4GlcNAc: a2,6-sialyltransferase . Nucl Acids Res . 1990;18:667–668
- . Tissue-specific alternative splicing of the Pgalactoside a2,6-sialyltransferase gene . J Biol Chem . 1992;267:2512–2518
- . Chromosome mapping and organization of the human Pgalactoside a2,6-sialyltransferase gene: differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells . J Biol Chem . 1993;268:4355–4361
- . Transcription of the beta-galactoside a2,6 sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter . Glycobiolojjy . 1996;6:271–279
- . Cell-specific expression of human beta-galactoside alpha 2,6-sialyltransferase transcripts differing in the 5' untranslated region . Eur J Biochem . 1993;213:467–475
PII: S1726-4901(09)70349-1
doi:10.1016/S1726-4901(09)70349-1
© 2007 Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 70, Issue 4 , Pages 152-158, April 2007
